Acquisitions11 Mar 2026, 01:52 pm
Earkart Ltd Approves Land Acquisition for Manufacturing Facility and Pharmaceutical Business Acquisition
AI Summary
Earkart Ltd, in a recent Board Meeting held on 11th March 2026, approved the acquisition of land for establishing a manufacturing facility and the acquisition of a Pharmaceutical Business. The decisions were made in accordance with Regulations 30 and 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The details of the meeting, including the acquisition decisions, were not provided to the Stock Exchange within the stipulated time due to the urgent nature of the matters. The company regrets the inconvenience caused and assures its commitment to adhering to SEBI regulations, taking necessary steps to prevent such delays in the future.
Key Highlights
- Earkart Ltd approved the acquisition of land for a manufacturing facility
- The company also approved the acquisition of a Pharmaceutical Business
- The decisions were made in accordance with Regulations 30 and 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
- The company acknowledges the delay in providing intimation to the Stock Exchange
- Earkart Ltd is committed to adhering to SEBI regulations and preventing future delays